We provide you with 20 years of free, institutional-grade data for JNJ stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of JNJ. Explore the full financial landscape of JNJ stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$40,390,741
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| MORIKIS JOHN G | Initial | 2025-09-15 | |||
| Taubert Jennifer L | Sale | -56,471 | $177.81 | $10,040,883 | 2025-09-05 |
| Taubert Jennifer L | Derivatives Exercise | 56,471 | 2025-09-05 | ||
| Forminard Elizabeth | Sale | -9,570 | $177.2 | $1,695,804 | 2025-09-03 |
| Forminard Elizabeth | Derivatives Exercise | 11,521 | 2025-09-03 | ||
| Duato Joaquin | Sale | -125,824 | $179.21 | $22,548,655 | 2025-08-25 |
| Duato Joaquin | Derivatives Exercise | 125,824 | 2025-08-25 | ||
| Wolk Joseph J | Sale | -16,820 | $176.91 | $2,975,571 | 2025-08-18 |
| Wolk Joseph J | Derivatives Exercise | 16,820 | 2025-08-18 | ||
| REED JOHN C | Sale | -19,137 | $163.55 | $3,129,830 | 2025-07-18 |
| REED JOHN C | Sale | -11,002 | $156.31 | $1,719,723 | 2025-05-05 |
| REED JOHN C | Derivatives Exercise | 25,255 | 2025-05-05 | ||
| Decker Robert J | Sale | -6,999 | $165.88 | $1,160,994 | 2025-02-26 |
| Decker Robert J | Derivatives Exercise | 6,999 | 2025-02-26 | ||
| REED JOHN C | Sale | -385 | $156.15 | $60,118 | 2025-02-18 |
| REED JOHN C | Derivatives Exercise | 1,350 | 2025-02-18 | ||
| Taubert Jennifer L | Sale | -10,320 | $155.26 | $1,602,283 | 2025-02-18 |
| Taubert Jennifer L | Derivatives Exercise | 22,414 | 2025-02-18 | ||
| Swanson James D. | Sale | -1,740 | $155.26 | $270,152 | 2025-02-18 |
| Swanson James D. | Derivatives Exercise | 6,018 | 2025-02-18 | ||
| Mulholland Kristen | Sale | -1,008 | $155.26 | $156,502 | 2025-02-18 |
| Mulholland Kristen | Derivatives Exercise | 3,438 | 2025-02-18 | ||
| Forminard Elizabeth | Sale | -1,253 | $155.26 | $194,541 | 2025-02-18 |
| Forminard Elizabeth | Derivatives Exercise | 3,815 | 2025-02-18 | ||
| Duato Joaquin | Sale | -13,696 | $155.26 | $2,126,441 | 2025-02-18 |
| Duato Joaquin | Derivatives Exercise | 31,487 | 2025-02-18 | ||
| Broadhurst Vanessa | Sale | -1,880 | $155.26 | $291,889 | 2025-02-18 |
| Broadhurst Vanessa | Derivatives Exercise | 5,640 | 2025-02-18 | ||
| Decker Robert J | Sale | -824 | $155.26 | $127,934 | 2025-02-18 |
| Decker Robert J | Derivatives Exercise | 2,852 | 2025-02-18 | ||
| Wolk Joseph J | Sale | -9,080 | $155.26 | $1,409,761 | 2025-02-18 |
| Wolk Joseph J | Derivatives Exercise | 23,080 | 2025-02-18 | ||
| Schmid Timothy | Sale | -2,250 | $156.71 | $352,598 | 2025-02-18 |
| Schmid Timothy | Derivatives Exercise | 6,099 | 2025-02-18 | ||
| Wengel Kathryn E | Sale | -3,296 | $155.26 | $511,737 | 2025-02-18 |
| Wengel Kathryn E | Derivatives Exercise | 8,625 | 2025-02-18 | ||
| Duato Joaquin | Sale | -100,643 | $153.12 | $15,410,456 | 2025-02-11 |
| Duato Joaquin | Derivatives Exercise | 126,369 | 2025-02-11 | ||
| Wengel Kathryn E | Sale | -26,076 | $153.12 | $3,992,757 | 2025-02-11 |
| Wengel Kathryn E | Derivatives Exercise | 32,762 | 2025-02-11 | ||
| Taubert Jennifer L | Sale | -47,436 | $153.12 | $7,263,400 | 2025-02-11 |
| Taubert Jennifer L | Derivatives Exercise | 58,504 | 2025-02-11 | ||
| Wolk Joseph J | Sale | -13,015 | $153.89 | $2,002,878 | 2025-02-11 |
| Wolk Joseph J | Derivatives Exercise | 13,015 | 2025-02-11 | ||
| WEINBERGER MARK A | Open Market Purchase | 1,000 | $147.22 | 2024-12-12 | |
| REED JOHN C | Sale | -10,984 | $144.59 | $1,588,177 | 2024-10-31 |
| REED JOHN C | Derivatives Exercise | 25,255 | 2024-10-31 | ||
| Mulholland Kristen | Initial | 2024-10-09 | |||
| Decker Robert J | Sale | -5,635 | $165.06 | $930,113 | 2024-09-03 |
| Decker Robert J | Derivatives Exercise | 5,635 | 2024-09-03 | ||
| Broadhurst Vanessa | Sale | -5,018 | $147.16 | $738,449 | 2024-07-09 |
| Broadhurst Vanessa | Derivatives Exercise | 9,809 | 2024-07-09 | ||
| REED JOHN C | Sale | -10,984 | $144.59 | $1,588,177 | 2024-05-03 |
| REED JOHN C | Derivatives Exercise | 22,255 | 2024-05-03 | ||
| Broadhurst Vanessa | Sale | -8,891 | $162.16 | $1,441,765 | 2024-03-13 |
| JOHNSON & JOHNSON | Derivatives Exercise | 3,855 | 2024-03-06 | ||
| JOHNSON & JOHNSON | Sale | -3,725 | $25.81 | $96,142 | 2024-03-06 |
The information provided in this report about JNJ stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Johnson & Johnson(NYSE:JNJ) 
Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Ba...
Website: http://www.jnj.com
Founded: 1886
Full Time Employees: 132,200
CEO: Alex Gorsky
Sector: Healthcare
Industry: Drug Manufacturers-General
